Effects of various adrenal inhibitors in low-renin essential hypertension.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 799736)

Published in J Steroid Biochem on June 11, 1977

Authors

G W Liddle, J W Hollifield, P E Slaton, H M Wilson

Articles citing this

Urinary kallikrein excretion in essential and mineralocorticoid hypertension. J Clin Invest (1980) 0.94

Articles by these authors

Lateral Roentgenometry of the Pelvis-A Newly Modified Technic. Yale J Biol Med (1937) 2.76

Normal and abnormal regulation of beta-msh in man. J Clin Invest (1969) 2.68

Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50

Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest (1967) 2.44

Roentgen Methods for Routine Obstetrical Pelvimetry. Yale J Biol Med (1938) 2.37

Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. J Clin Invest (1970) 2.18

Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res (1969) 2.16

The ectopic ACTH syndrome. Cancer Res (1965) 1.97

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A (1996) 1.87

Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest (1970) 1.86

Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med (1971) 1.69

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action. J Clin Endocrinol Metab (1967) 1.68

Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62

Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther (1976) 1.62

Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest (1972) 1.52

Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine. J Clin Invest (1970) 1.49

Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. N Engl J Med (1976) 1.47

Postoperative studies of adrenal function in primary aldosteronism. J Clin Endocrinol Metab (1966) 1.45

Thiazide diuretics, hypokalemia and cardiac arrhythmias. Acta Med Scand Suppl (1981) 1.45

Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest (1967) 1.42

The Roentgenological Survey of the Pelvis. Yale J Biol Med (1941) 1.40

Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension. Arch Intern Med (1967) 1.33

A diurnal rhythm in plasma renin activity in man. J Clin Invest (1966) 1.32

Sustained hypertension after section of the glossopharyngeal nerve. Am J Med (1977) 1.30

Revascularization of the poorly functioning kidney. Surgery (1979) 1.30

Adenosine 3',5'-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin. Endocrinology (1969) 1.29

In vitro stimulation of renin production by epinephrine, norepinephrine, and cyclic AMP. Proc Soc Exp Biol Med (1969) 1.28

Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med (1979) 1.26

The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone. Arch Intern Med (1972) 1.23

The influence of cholestyramine on thyroxine absorption. JAMA (1969) 1.22

Effect of diazoxide on plasma renin activity in hypertensive patients. Ann Intern Med (1967) 1.22

Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol (1979) 1.22

Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg (1981) 1.21

Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab (1973) 1.20

Operative management of renovascular hypertension. Results after a follow-up of fifteen to twenty-three years. J Vasc Surg (1984) 1.20

Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. J Clin Invest (1974) 1.18

Results of treating childhood Cushing's disease with pituitary irradiation. N Engl J Med (1977) 1.17

Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome. J Clin Invest (1973) 1.17

Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. J Clin Invest (1974) 1.17

ACTH antibodies in patients receiving depot porcine ACTH to hasten recovery from pituitary-adrenal suppression. J Clin Invest (1967) 1.16

Studies of ACTH antibodies and their reactions with inactive analogues of ACTH. Endocrinology (1966) 1.15

Graves' disease without hyperthyroidism. Am J Med (1965) 1.14

Effects of amino-glutethimide on adrenal function in man. J Clin Endocrinol Metab (1967) 1.14

A method of preparing adrenal cell suspensions and its applicability to the in vitro study of adrenal metabolism. Endocrinology (1968) 1.13

Studies of the mechanism through which sodium depletion increases aldosterone biosynthesis in man. J Clin Invest (1966) 1.12

Radioimmunologic evidence for alpha-MSH (melanocyte stimulating hormone) in human pituitary and tumor tissues. J Clin Endocrinol Metab (1967) 1.10

Reduced aldosterone excretion in patients with autonomic insufficiency. J Clin Endocrinol Metab (1967) 1.09

Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color. Endocrinology (1969) 1.06

Differences between ectopic MSH and pituitary MSH. J Clin Endocrinol Metab (1971) 1.06

Comparative effects of angiotensin and ACTH on cyclic AMP and steroidogenesis in isolated bovine adrenal cells. J Clin Invest (1973) 1.04

The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res (1978) 1.03

Comparative fates of intravenously and orally administered aldosterone: evidence for extrahepatic formation of acid-hydrolyzable conjugate in man. J Clin Invest (1966) 1.03

Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. Am J Med (1986) 1.02

Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Trans Assoc Am Physicians (1976) 1.02

Effect of an adrenal inhibitor in hypertensive patients with suppressed renin. Arch Intern Med (1969) 1.02

The intercurrent hypertension of primary aldosteronism. Circ Res (1970) 1.02

Surgical experience with Cushing's disease. Ann Surg (1977) 1.01

Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur J Cancer (1996) 1.01

Extracellular cyclic nucleotides. Ann N Y Acad Sci (1971) 1.01

Analysis of circadian rhythms in human adrenocortical secretory activity. Arch Intern Med (1966) 0.99

An analysis of factors determining the circadian pattern of aldosterone excretion. J Clin Endocrinol Metab (1966) 0.98

Identification of a naturally occurring goitrogen in water. Trans Assoc Am Physicians (1969) 0.97

Inhibitors of adrenal steroid biosynthesis. Annu Rev Pharmacol (1970) 0.97

Surgical management of adrenocortical tumors with Cushing's syndrome. Ann Surg (1971) 0.97

Macrophage subtypes in symptomatic carotid artery and femoral artery plaques. Eur J Vasc Endovasc Surg (2012) 0.96

An effect of adrenocorticotrophic hormone on adrenal cholesterol accumulation. Endocrinology (1967) 0.96

Inhibition of propranolol metabolism by chlorpromazine. Clin Pharmacol Ther (1979) 0.96

Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency. N Engl J Med (1969) 0.96

Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA (1968) 0.95

Preliminary characterization of the pituitary melanocyte stimulating hormones of several vertebrate species. Endocrinology (1972) 0.95

Hypermineralocorticoidism. Am J Med (1968) 0.95

Cyclic adenosine monophosphate as a mediator of hormone action. N Engl J Med (1971) 0.95

Mineralocorticoid production in hyperadrenocorticism. Role in pathogenesis of hypokalemic alkalosis. Am J Med (1971) 0.95

An explanation for the target organ unresponsiveness to testosterone in the testicular feminization syndrome. J Clin Endocrinol Metab (1969) 0.94

Plasma renin activity and aldosterone secretion in a pregnant woman with primary aldosteronism. J Clin Endocrinol Metab (1967) 0.94

Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. Am J Med (1984) 0.94

Magnesium depletion, diuretics, and arrhythmias. Am J Med (1987) 0.93

Renin-secreting clear cell carcinoma of the kidney. Arch Intern Med (1975) 0.93

Influence of hypertonic saline on canine renal blood flow and renin release. Am J Physiol (1979) 0.92

Aldosterone antagonists and triamterene. Ann N Y Acad Sci (1966) 0.92

Cushing's syndrome. Ann N Y Acad Sci (1977) 0.92

The participation of prostaglandins in the control of renin release. Fed Proc (1979) 0.91

Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention. Circ Res (1979) 0.90

Pathogenesis of glucocorticoid disorders. Am J Med (1972) 0.90

Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br J Clin Pharmacol (1996) 0.89

Renovascular hypertension in children. Pediatrics (1970) 0.88

Primary aldosteronism with unusual secretory pattern. J Clin Endocrinol Metab (1967) 0.88

Experimental alteration of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J Clin Endocrinol Metab (1967) 0.88

Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology (1981) 0.88

Angiotensin stimulates both early and late steps in aldosterone biosynthesis in isolated bovine glomerulosa cells. J Steroid Biochem (1978) 0.87

Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension. Hypertension (1981) 0.86

Site of stimulation of aldosterone biosynthesis by angiotensin and potassium. J Clin Invest (1972) 0.86

Stimulation of adrenal ornithine decarboxylase by adrenocorticotropin and growth hormone. Endocrinology (1973) 0.85

Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun (1993) 0.85

Surgical experience with hyperparathyroidism. Am Surg (1981) 0.85

A predictable error in use of renal vein renin in diagnosing hypertension. Arch Intern Med (1969) 0.85

Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells. J Clin Invest (1979) 0.85

The effects of potassium on early and late steps in aldosterone biosynthesis in cells of the zona glomerulosa. Endocrinology (1978) 0.85

Conidia of Botrytis cinerea: labeling by fluorescent vital staining. Science (1966) 0.85